Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587365 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT01587365 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 66 participants.
The verdict
NCT01587365, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
To obtain safety and tolerability information in healthy subjects is administered as a single dose
Interventions
- BIOLOGICAL BMS-962476
- BIOLOGICAL Placebo matching with BMS-962476
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587365
The ClinicalTrials.gov registry entry for NCT01587365 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BMS-962476 is the first listed.
NCT01587365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587365 about?
NCT01587365 is a clinical study titled "Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins". To obtain safety and tolerability information in healthy subjects is administered as a single dose
What is the current status of trial NCT01587365?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2012-05. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01587365?
The interventions under investigation include: BMS-962476 (BIOLOGICAL), Placebo matching with BMS-962476 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01587365?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.